Back to search
Non-alcoholic Fatty Liver Disease, Renal Function Impairment
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-alcoholic Fatty Liver Disease, Renal Function Impairment trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-alcoholic Fatty Liver Disease, Renal Function Impairment trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a single-center retrospective observational study. A total of 300 patients with non-alcoholic fatty liver disease treated in our hospital will be includ…
Novo Nordisk is developing the study medicine NNC0194-0499 for the treatment of non-alcoholic steatohepatitis (NASH). NASH is a serious disease where fat, infla…